The Myeloma and Autologous Stem Cell Transplant Service of the Parkville Integrated Haematology Service is composed of medical and nursing staff from both Peter Mac and the Royal Melbourne Hospital. Our inpatient service is located in the new 24-bed ward on level 3 in the Parkville Peter Mac building on the south side of Grattan Street. Ambulatory care services are delivered in new facilities on level 5.
Our radiotherapy doctors are A/Prof. Andrew Wirth, Prof. Michael MacManus and Dr Belinda Campbell.
We aim to deliver world-class, evidence-based treatment via a highly effective multidisciplinary care team to young and old patients who require therapy to control their disease. We also offer intensive chemotherapy and autologous stem cell transplantation to fit patients with multiple myeloma, other plasma cell dyscrasias, lymphoma, germ cell tumours and sarcoma to induce long-lasting disease control.
Tuesday afternoons and Friday mornings
We have a comprehensive clinical trials program dedicated to developing new drugs and novel combinations that we can offer all of our patients, young and old, at all points of the disease journey.
Every patient who participates in a clinical trial is an integral part of the trials team, and we are committed to pursuing state-of-the-art research from bench to bedside and back again, as well as in other areas such as supportive care and epidemiology.
If you would like to participate in a research project or have questions about clinical trials, speak to your specialist.
We understand how stressful and difficult cancer can be.
Your Peter Mac team of experts are dedicated and sensitive to your individual health and wellbeing needs - we are here to help.
You will need a referral from your GP or medical practitioner to access this service.
For health professionals
Visit the referrals page for further information